Prevalence, Patterns of Treatment, and Control of Hypertension in Predialysis Patients with Chronic Kidney Disease
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background/Aims: Data on the prevalence, treatment and control of hypertension in patients with advanced chronic kidney disease (CKD) are limited. This study aimed to examine the above factors in a cohort of predialysis patients. Methods: During a period of 4 months, we recorded information on blood pressure (BP), comorbidities, medications and related parameters of patients followed up in the Low-Clearance Clinic of our Department. Control rates of hypertension were calculated at two thresholds: <130/80 and <140/90 mm Hg. Univariate and multiple linear regression analyses were employed to assess factors associated with BP control. Results: In the population studied [n = 238, males 58.4%, age 66.21 ± 4.2 years (mean ± SD), estimated glomerular filtration rate 14.5 ± 4.8 ml/min/1.73 m 2], the prevalence of hypertension was 95.0%. Treatment rate among hypertensives was at 99.1%. On average, 3.04 ± 1.32 antihypertensive drugs were used, ranging from 1 to 7 agents. BP control rates at the <130/80 and <140/90 mm Hg thresholds were 26.5% and 48.2%, respectively. The systolic goal was achieved in 31.0% and 50.4%, whereas the diastolic goal was achieved in 67.7% and 91.2% of patients, respectively. In multivariate analysis, only black race was independently and inversely related with hypertension control (β = –0.187, p = 0.030). No specific antihypertensive class showed independent associations with control. Conclusions: Hypertension is highly prevalent in predialysis CKD patients. An almost universal treatment, employing a multi-agent regime, can help towards improved rates of control. Systolic BP is the main barrier to successful control and black race is associated with poorer control rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004
Ong, K. L., Cheung, B. M. Y., Man, Y. B., Lau, C. P., & Lam, K. S. L. (2007) · Hypertension · doi:10.1161/01.hyp.0000252676.46043.18 · Cited by 1,395
Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.7.844 · Cited by 1,241
Muntner, P., Anderson, A., Charleston, J., Chen, Z., Ford, V., Makos, G., O'Connor, A., Perumal, K., Rahman, M., Steigerwalt, S., et al. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.09.014 · Cited by 423
Cited by
Prevalence of Apparent Treatment-Resistant Hypertension among Individuals with CKD
Tanner, R. M., Calhoun, D. A., Bell, E. K., Bowling, C. B., Gutiérrez, O. M., Irvin, M. R., Lackland, D. T., Oparil, S., Warnock, D., & Muntner, P. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00550113 · Cited by 168
Parati, G., Ochoa, J. E., Bilo, G., Agarwal, R., Covic, A., Dekker, F. W., Fliser, D., Heine, G. H., Jager, K. J., Gargani, L., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06895 · Cited by 76
“Population studies with CBP measurements have shown hypertension prevalence around 70% to 80% in patients with stage 1 CKD, whereas in stages 4 and 5 before initiation of dialysis, this rate increases to >95%.(25,26) CBP measurements are less than ideal to guide hypertension treatment in CKD.”
BackgroundSelf-citationHyperkalemia in chronic kidney disease: a focus on potassium lowering pharmacotherapy
Sampani, E., Theodorakopoulou, M., Iatridi, F., & Sarafidis, P. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2245756 · Cited by 11
Self-citation
Metadata
- Authors
- Sarafidis, P. A., Sharpe, C. C., Wood, E., Blacklock, R., Rumjon, A., Al-Yassin, A., Ariyanayagam, R., Simmonds, S., Fletcher-Rogers, J., & Vinen, K.
- Venue
- Nephron Clinical Practice
- Publisher
- S. Karger AG
- Published
- 2012-06-05
- Volume
- 120
- Issue
- 3
- Pages
- c147-c155
- ISSN
- 1660-2110 (ISSN-L)
- OpenAlex
- W1978365402
- Cited by
- 49
- References
- 4
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence, Patterns of Treatment, and Control of Hypertension in Predialysis Patients with Chronic Kidney Disease. https://app.cochat.ai/papers/10.1159/000337571
- The paper
- Sarafidis, P. A., Sharpe, C. C., Wood, E., Blacklock, R., Rumjon, A., Al-Yassin, A., Ariyanayagam, R., Simmonds, S., Fletcher-Rogers, J., & Vinen, K. (2012). Prevalence, Patterns of Treatment, and Control of Hypertension in Predialysis Patients with Chronic Kidney Disease. Nephron Clinical Practice. https://doi.org/10.1159/000337571
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.